BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30790545)

  • 21. Interference of Therapeutic Monoclonal Antibodies With Routine Serum Protein Electrophoresis and Immunofixation in Patients With Myeloma: Frequency and Duration of Detection of Daratumumab and Elotuzumab.
    Tang F; Malek E; Math S; Schmotzer CL; Beck RC
    Am J Clin Pathol; 2018 Jul; 150(2):121-129. PubMed ID: 29901687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
    Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
    J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Success rate, economic analysis, and clinical outcome.
    Ge MC; Kuo AJ; Liu KL; Wen YH; Chia JH; Chang PY; Lee MH; Wu TL; Chang SC; Lu JJ
    J Microbiol Immunol Infect; 2017 Oct; 50(5):662-668. PubMed ID: 27426930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid identification of Mycobacterium avium clinical isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Lin CS; Su CC; Hsieh SC; Lu CC; Wu TL; Jia JH; Wu TS; Han CC; Tsai WC; Lu JJ; Lai HC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):205-12. PubMed ID: 24113069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
    Mills JR; Kohlhagen MC; Dasari S; Vanderboom PM; Kyle RA; Katzmann JA; Willrich MA; Barnidge DR; Dispenzieri A; Murray DL
    Clin Chem; 2016 Oct; 62(10):1334-44. PubMed ID: 27540026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct identification of trypanosomatids by matrix-assisted laser desorption ionization-time of flight mass spectrometry (DIT MALDI-TOF MS).
    Avila CC; Almeida FG; Palmisano G
    J Mass Spectrom; 2016 Aug; 51(8):549-57. PubMed ID: 27659938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium heckeshornense lung infection diagnosed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
    Yokoyama A; Kage H; Ohama Y; Sato T; Miyashita N; Noguchi S; Okugawa S; Yamauchi Y; Moriya K; Nagase T
    J Infect Chemother; 2018 Sep; 24(9):763-765. PubMed ID: 29503226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and serum exosome markers analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry coupled with electron multiplier.
    Shan L; Gao H; Zhang J; Li W; Su Y; Guo Y
    Talanta; 2022 Sep; 247():123560. PubMed ID: 35623246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting monoclonal immunoglobulins in human serum using mass spectrometry.
    Mills JR; Barnidge DR; Murray DL
    Methods; 2015 Jun; 81():56-65. PubMed ID: 25916620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify low level monoclonal proteins.
    Campbell L; Simpson D; Ramasamy K; Sadler R
    Clin Biochem; 2021 Sep; 95():81-83. PubMed ID: 34058191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
    Kohlhagen MC; Barnidge DR; Mills JR; Stoner J; Gurtner KM; Liptac AM; Lofgren DI; Vanderboom PM; Dispenzieri A; Katzmann JA; Willrich MA; Snyder MR; Murray DL
    Clin Chem; 2016 Oct; 62(10):1345-52. PubMed ID: 27515443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
    Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
    Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry.
    Pečinka L; Vlachová M; Moráň L; Gregorová J; Porokh V; Kovačovicová P; Almáši M; Pour L; Štork M; Havel J; Ševčíková S; Vaňhara P
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2646-2653. PubMed ID: 37994781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation.
    Lee H; Park JH; Oh J; Cho S; Koo J; Park IC; Kim J; Park S; Choi JS; Shin SY; Sung GH; Kim J
    J Clin Lab Anal; 2019 Feb; 33(2):e22685. PubMed ID: 30298531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory.
    Bizzini A; Durussel C; Bille J; Greub G; Prod'hom G
    J Clin Microbiol; 2010 May; 48(5):1549-54. PubMed ID: 20220166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Cheng Z; Winant RC; Gambhir SS
    J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.
    Tsuchida S; Umemura H; Nakayama T
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33080897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Matrix-assisted laser desorption/ionization Time-of flight Mass spectrometry (MALDI TOF MS) and VITEK 2 in routine microbial identification.
    Madhavan A; Sachu A; Sethuraman N; Kumar A; Vasudevapanicker J
    Ghana Med J; 2021 Dec; 55(4):308-310. PubMed ID: 35957934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.